Blow out sales and strong cash on recent quarter.
Bottom formation is done and should bode well.
Jan-14 : FDA approval for HCC due.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
